Medicare Drug Price Cuts: More Drugs, Lower Taxpayer Costs.
This bill aims to lower drug prices for Medicare beneficiaries. It will increase the number of drugs subject to price negotiation and accelerate the negotiation process. This means potentially lower out-of-pocket costs for seniors and people with disabilities, and savings for taxpayers.
Key points
More drugs will have negotiated prices, potentially reducing costs for patients.
The drug price negotiation process will be sped up, leading to quicker savings.
Rules for setting maximum fair drug prices will be adjusted, potentially leading to further reductions.
Introduced
Citizen Poll